COMMON STOCK PURCHASE WARRANT REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • October 13th, 2017 • Pharmaceutical preparations
Company FiledOctober 13th, 2017 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ____, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 19th, 2018 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 19th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 17, 2018, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ARTICLE IAgreement and Plan of Merger • January 21st, 2005 • Corporate Road Show Dot Com Inc • Services-motion picture & video tape production
Contract Type FiledJanuary 21st, 2005 Company Industry
ARTICLE II GENERAL RELEASESettlement Agreement • May 23rd, 2005 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2005 Company Industry Jurisdiction
FORM OF COMMON STOCK PURCHASE WARRANTRexahn Pharmaceuticals, Inc. • January 25th, 2019 • Pharmaceutical preparations • New York
Company FiledJanuary 25th, 2019 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or his, her or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 25, 2019 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 25, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock (as defined below). The purchase price of one (1) share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT OCUPHIRE PHARMA, INC.Common Stock Purchase Warrant • June 4th, 2021 • Ocuphire Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledJune 4th, 2021 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on June 8, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Debt SecuritiesIndenture • February 4th, 2021 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 4th, 2021 Company Industry JurisdictionTHIS INDENTURE, dated as of [●], 20___, between Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 15th, 2014 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 15th, 2014 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 15, 2014, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
OCUPHIRE PHARMA, INC. AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF ______________Warrant Agreement • January 10th, 2024 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2024 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER This Agreement and Plan of Merger (the "Agreement") is made as of the 20th day of January, 2005 by and among Corporate Road Show.Com Inc., a New York corporation (the "Company"), CRS Merger Sub, Inc., a...Agreement and Plan of Merger • January 21st, 2005 • Corporate Road Show Dot Com Inc • Services-motion picture & video tape production • New York
Contract Type FiledJanuary 21st, 2005 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 7th, 2017 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 7th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 6, 2017, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
OCUPHIRE PHARMA, INC.Ocuphire Pharma, Inc. • March 11th, 2021 • Pharmaceutical preparations • New York
Company FiledMarch 11th, 2021 Industry JurisdictionOcuphire Pharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2010 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 29th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2010, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
OCUPHIRE PHARMA, INC. AND __________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF _____________Common Stock Warrant Agreement • January 10th, 2024 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2024 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
OCUPHIRE PHARMA, INC. AND ___________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF _________Warrant Agreement • January 10th, 2024 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2024 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
COMMON STOCK WARRANT REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • October 16th, 2013 • Pharmaceutical preparations
Company FiledOctober 16th, 2013 IndustryTHIS COMMON STOCK WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________ (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the date this Warrant is issued (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
19,130,435 SHARES OF COMMON STOCK AND 10,521,739 WARRANTS OF REXAHN PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2012 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 30th, 2012 Company Industry JurisdictionThe undersigned, Rexahn Pharmaceuticals, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Rexahn Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representatives (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Burrill LLC and Maxim Group LLC (collectively, the “Representatives” and each a “Representative” and if there are no Underwriters other than the Representatives, references to Underwriters shall be disregarded and the term Representatives as used herein shall have the same meaning as Underwriters) are acting as joint representatives for the several Underwriters on the terms and conditions set forth herein.
PURCHASE AGREEMENTPurchase Agreement • August 11th, 2023 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • Illinois
Contract Type FiledAugust 11th, 2023 Company Industry JurisdictionPURCHASE AGREEMENT (the “Agreement”), dated as of August 10, 2023, by and between OCUPHIRE PHARMA, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
COMMON STOCK PURCHASE WARRANT REXAHN PHARMACEUTICALS, INC.Common Stock Purchase • October 19th, 2018 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2018 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ____, 2019 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one (1) share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • June 29th, 2010 • Pharmaceutical preparations
Company FiledJune 29th, 2010 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______ ___, 2010 (the “Initial Exercise Date”) and on or prior to the close of business on the four (4) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.
REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • March 16th, 2015 • Pharmaceutical preparations • New York
Company FiledMarch 16th, 2015 Industry JurisdictionRexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
OCUPHIRE PHARMA, INC. INDEMNITY AGREEMENTIndemnity Agreement • November 6th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 6th, 2020 Company Industry JurisdictionThis Indemnity Agreement (this “Agreement”) is made and entered into as of _______________, by and between Ocuphire Pharma, Inc. a Delaware corporation (the “Company”), and [Insert Name] (“Indemnitee”).
ContractRexahn Pharmaceuticals, Inc. • May 20th, 2009 • Pharmaceutical preparations
Company FiledMay 20th, 2009 Industry
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: REXAHN PHARMACEUTICALS, INC., a Delaware corporation; RAZOR MERGER SUB, INC., a Delaware corporation; and OCUPHIRE PHARMA, INC. a Delaware corporation Dated as of June 17, 2020Agreement and Plan of Merger and Reorganization • August 14th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 14th, 2020 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of June 17, 2020, by and among REXAHN PHARMACEUTICALS, INC., a Delaware corporation (“Parent”), RAZOR MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and OCUPHIRE PHARMA, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 6th, 2023 • Ocuphire Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 6th, 2023 Company IndustryTHIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between OCUPHIRE PHARMA, INC., a Delaware corporation (the “Company”), and RONIL PATEL (the “Executive”) is signed by the Company and the Executive and is entered into on and made effective as of April 24, 2023 (as defined below) (the “Effective Date”).
January 20, 2005Corporate Road Show Dot Com Inc • January 21st, 2005 • Services-motion picture & video tape production
Company FiledJanuary 21st, 2005 IndustryThe undersigned, the owner of shares of common stock, par value $.0001 per share (the "Company Common Stock"), of Corporate Road Show.Com, Inc., a New York corporation (the "Company"), understands that, pursuant to the Agreement and Plan of Merger dated as of January 20, 2005 (the "Merger Agreement") by and among the Company, CRS Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("Merger Sub"), CRS Delaware, Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("CRS Delaware"), and Rexahn, Corp, a Maryland corporation ("Rexahn"), Merger Sub will merge with and into Rexahn (the "Merger"), with Rexahn as the surviving corporation. As a condition to its willingness to approve the terms of and to enter into the Merger Agreement, Rexahn has required that the undersigned deliver this letter (this "Letter").
COMMON STOCK PURCHASE WARRANT REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • November 30th, 2012 • Pharmaceutical preparations • New York
Company FiledNovember 30th, 2012 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on July 5, 20161 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to Section 2.3(ii) of the Underwriting Agreement, dated as of November __, 2012, between the Company and Burrill LLC and Maxim Group LLC.
INDEMNIFICATION AGREEMENT Effective Date: [_______]Indemnification Agreement • July 6th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 6th, 2020 Company Industry JurisdictionTHIS INDEMMICATION AGREEMENT (this “Agreement”), is made as of the Effective Date set forth above, between OCUPHIRE PHARMA INC., a Delaware corporation (the “Company”), whose address is 6894 Lakemont Circle, West Bloomfield, MI 48323, and [_______] (“Indemnitee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 11th, 2023 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • Illinois
Contract Type FiledAugust 11th, 2023 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 10, 2023, by and between OCUPHIRE PHARMA, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2011 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2011 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2011, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
WITNESSETH:Employment Agreement • August 19th, 2003 • Corporate Road Show Dot Com Inc • Services-motion picture & video tape production • New York
Contract Type FiledAugust 19th, 2003 Company Industry Jurisdiction
Exhibit 10.3 CORPORATE ROAD SHOW.COM INC. 2003 OMNIBUS PLAN STOCK OPTION AGREEMENT Unless otherwise defined herein, the terms defined in the 2003 Omnibus Plan (the "Plan") shall have the same defined meanings in this Stock Option Agreement. 1. NOTICE...Plan Stock Option Agreement • August 19th, 2003 • Corporate Road Show Dot Com Inc • Services-motion picture & video tape production • New York
Contract Type FiledAugust 19th, 2003 Company Industry Jurisdiction
AGREEMENT -------------------------------------------------------------- Client: Corporate Roadshow -------------------------------------------------------------- Address: 45 Church Street Suite 100...Agreement • August 19th, 2003 • Corporate Road Show Dot Com Inc • Services-motion picture & video tape production
Contract Type FiledAugust 19th, 2003 Company Industry
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 16th, 2013 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 16th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 10, 2013, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ContractSecurities Purchase Agreement • March 26th, 2008 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 26th, 2008 Company Industry